Akari Therapeutics, Statistics

Total Valuation

AKTX has a market cap or net worth of $36.04 million. The enterprise value is $35.30 million.

Market Cap	36.04M
Enterprise Value	35.30M

Important Dates

The next estimated earnings date is Monday, August 18, 2025, after market close.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

AKTX has 32.18 million shares outstanding. The number of shares has increased by 202.84% in one year.

Current Share Class	n/a
Shares Outstanding	32.18M
Shares Change (YoY)	+202.84%
Shares Change (QoQ)	+40.63%
Owned by Insiders (%)	81.31%
Owned by Institutions (%)	0.97%
Float	5.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.49
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16, with a Debt / Equity ratio of 0.08.

Current Ratio	0.16
Quick Ratio	0.12
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-47.43

Financial Efficiency

Return on equity (ROE) is -197.11% and return on invested capital (ROIC) is -88.47%.

Return on Equity (ROE)	-197.11%
Return on Assets (ROA)	-33.00%
Return on Invested Capital (ROIC)	-88.47%
Return on Capital Employed (ROCE)	-47.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.99M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.49% in the last 52 weeks. The beta is 0.25, so AKTX's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-60.49%
50-Day Moving Average	1.29
200-Day Moving Average	1.63
Relative Strength Index (RSI)	40.06
Average Volume (20 Days)	25,397

Short Selling Information

Short Interest	117,901
Short Previous Month	118,286
Short % of Shares Out	0.57%
Short % of Float	n/a
Short Ratio (days to cover)	7.96

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.18M
Pretax Income	n/a
Net Income	-17.93M
EBITDA	-14.18M
EBIT	-14.18M
Earnings Per Share (EPS)	-$1.05

Full Income Statement

Balance Sheet

The company has $2.58 million in cash and $1.85 million in debt, giving a net cash position of $736,000 or $0.02 per share.

Cash & Cash Equivalents	2.58M
Total Debt	1.85M
Net Cash	736,000
Net Cash Per Share	$0.02
Equity (Book Value)	21.75M
Book Value Per Share	0.75
Working Capital	-17.56M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.66M
Capital Expenditures	n/a
Free Cash Flow	-10.66M
FCF Per Share	-$0.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-202.84%
Shareholder Yield	-202.84%
Earnings Yield	-49.75%
FCF Yield	-29.57%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 17, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Aug 17, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1